NEW YORK, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have
commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead
plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links
provided. There is no cost or obligation to you.
The Goldman Sachs Group, Inc. (NYSE: GS)
Class Period: February 28, 2014 - December 17, 2018
Lead Plaintiff Deadline: February 19, 2019
Join the action: https://www.zlk.com/pslra-1/the-goldman-sachs-group-inc-loss-form?wire=3
The lawsuit alleges: The Goldman Sachs Group, Inc. made materially false and/or misleading statements throughout the class
period and/or failed to disclose that: (1) Goldman Sachs participated in a fraud and money-laundering scheme in collusion with
1Malaysia Development Bhd., a Malaysian state-owned investment fund; (2) the foregoing conduct, when revealed, would foreseeably
subject Goldman Sachs to heightened regulatory investigations and enforcement; and (3) as a result, Goldman Sachs’s public
statements were materially false and misleading at all relevant times.
To learn more about the The Goldman Sachs Group, Inc. class action contact jlevi@levikorsinsky.com.
Altice USA, Inc. (NYSE: ATUS)
Class Period: Pursuant and/or traceable to the June 2017 Initial Public Offering
Lead Plaintiff Deadline: January 18, 2019
Join the action: https://www.zlk.com/pslra-1/altice-usa-inc-loss-form?wire=3
The complaint alleges that the Offering Documents issued pursuant to the IPO failed to disclose and/or misstated material
information, including that: (1) “The Altice Way” proprietary growth model previously developed in Europe and described in the
Offering Documents as a means to achieve superior margin performance was falsely touting Altice’s capacity to face already existing
highly competitive environments and ever-changing consumer behaviors; (2) Altice was suffering from aggressively growing
competition both in Europe and the United States, directly causing negative and decelerating revenue and EBITDA growth and
impacting Altice’s market share; (3) specifically, Altice was suffering from mismanaged rate events, regulatory compliance and
poorly managed network and customer care both in its France and Portugal segments, thereby impacting its customer base and churn
rate; (4) Altice USA could not simply replicate the “The Altice Way” in the U.S.; and (5) as a result, Altice USA’s Offering
Documents were materially misleading at all relevant times.
To learn more about the Altice USA, Inc. class action contact jlevi@levikorsinsky.com.
Dentsply Sirona, Inc. (NASDAQ: XRAY)
Class Period: (i) all persons who purchased the common stock of Dentsply Sirona, Inc. (NASDAQ: XRAY) between February 20,
2014 and August 7, 2018; (ii) all Dentsply International Inc. shareholders who held shares as of the record date of December 2,
2015 and were entitled to vote with respect to the Acquisition at the January 11, 2016 special meeting of Dentsply International
Inc. shareholders; and (iii) all persons who purchased or otherwise acquired the common stock of Dentsply International in exchange
for their shares of common stock of Sirona in connection with the Acquisition
Lead Plaintiff Deadline: February 9, 2019
Join the action: https://www.zlk.com/pslra-1/dentsply-sirona-inc-loss-form?wire=3
The complaint alleges that during the Class Period, Defendants attributed the Company’s financial performance to the Company’s
“innovation,” “operational improvement efforts,” “new products,” and “continued investments in sales and marketing” and told
investors that these factors helped the Company succeed despite the “highly competitive” market for its products. In reality, the
Company’s financial results had been buoyed by an anticompetitive scheme among the Company’s three primary distributors that
suppressed competition in the dental supply market and artificially inflated the price of dental supplies sold by Dentsply.
Further, Defendants concealed that an exclusive distribution arrangement that Sirona had with one of its distributors, Patterson
Companies, Inc. (“Patterson”), required Patterson to regularly make large minimum purchases regardless of demand and, as a result,
by 2015, Patterson had been supplied with so much excess inventory that it could not be sold. This channel-stuffing rendered the
Company’s reported sales, financial results and guidance materially false and misleading. In addition, the Company
represented that it reported its financial statements, including its goodwill, in accordance with generally accepted accounting
principles, or GAAP. In fact, the Company’s reported goodwill was artificially inflated and not reported in accordance with GAAP
because it did not reflect the financial impact of the anticompetitive scheme.
To learn more about the Dentsply Sirona, Inc. class action contact jlevi@levikorsinsky.com.
NVIDIA Corporation (NASDAQGS: NVDA)
Class Period: August 10, 2017 - November 15, 2018
Lead Plaintiff Deadline: February 19, 2019
Join the action: https://www.zlk.com/pslra-1/nvidia-corporation-loss-form?wire=3
Throughout the Class Period, in response to analysts’ questions on the Company’s ability to manage inventory in the fact of
uncertain cryptocurrency markets, Defendants assured investors that they were following the cryptocurrency markets closely and
could therefore adjust to possible rapid changes. Defendants then touted that the Company and its executives were “masters at
managing [its] channel” and “understand the channel very well.” Moreover, NVIDIA assured investors that surging demand for GPUs
among cryptocurrency miners would not have a negative impact on the Company because of a strong demand for GPUs by NVIDIA's core
customer base of computer gamers. These statements were false and misleading. As a result of these misrepresentations, NVIDIA
shares traded at artificially inflated prices throughout the Class Period.
To learn more about the NVIDIA Corporation class action contact jlevi@levikorsinsky.com.
You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any
recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys
have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of
dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com